Clinical Trial Update: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial MK-8748 (EYE201) for age-related macular degeneration is described in this update. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization
• Wet Age-related Macular Degeneration

Drugs mentioned

• MK-8748 (EYE201) (MK-8748)

Snippet

Sponsor: EyeBiotech Ltd. | Conditions: Macular Degeneration, Age-Related Macular Degeneration | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING